Literature DB >> 22488646

Preventing diabetes mellitus in developing countries.

Justin B Echouffo-Tcheugui1, Samuel Dagogo-Jack.   

Abstract

By the year 2030, >70% of people living with T2DM will reside in developing countries, and primary prevention of T2DM should be an urgent priority for such regions. The disease predominantly affects working-age persons and has a devastating economic impact, compounded by the frequent occurrence and interaction of T2DM with infectious diseases (such as AIDS and tuberculosis). Evidence from landmark T2DM prevention trials indicates that lifestyle modification is more effective, cheaper and safer than medication and provides sustained benefits. Lifestyle modification is, therefore, the most promising approach to T2DM prevention in developing countries; however, programmes adapted to their specific needs are lacking. Low-cost strategies to identify at-risk individuals, followed by the implementation of group-based, inexpensive lifestyle interventions, seem to be the best options for resource-poor countries. However, widespread implementation of T2DM prevention in developing countries will require coordinated efforts throughout society, along with comprehensive government policies and novel funding sources.

Entities:  

Mesh:

Year:  2012        PMID: 22488646     DOI: 10.1038/nrendo.2012.46

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  40 in total

1.  Global healthcare expenditure on diabetes for 2010 and 2030.

Authors:  Ping Zhang; Xinzhi Zhang; Jonathan Brown; Dorte Vistisen; Richard Sicree; Jonathan Shaw; Gregory Nichols
Journal:  Diabetes Res Clin Pract       Date:  2010-02-19       Impact factor: 5.602

2.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

3.  Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).

Authors:  Ambady Ramachandran; Chamukuttan Snehalatha; Annasami Yamuna; Simon Mary; Zhang Ping
Journal:  Diabetes Care       Date:  2007-08-01       Impact factor: 19.112

4.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

5.  Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.

Authors: 
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 7.  Diabetes care in sub-Saharan Africa.

Authors:  David Beran; John S Yudkin
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

8.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

9.  Incidence of diabetes following ramipril or rosiglitazone withdrawal.

Authors: 
Journal:  Diabetes Care       Date:  2011-04-22       Impact factor: 19.112

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  16 in total

Review 1.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

2.  The Influence of the Smart Glucose Manager Mobile Application on Diabetes Management.

Authors:  Kasun C Gunawardena; Renee Jackson; Iva Robinett; Lahiru Dhaniska; Shaluka Jayamanne; Sumedha Kalpani; Dimuthu Muthukuda
Journal:  J Diabetes Sci Technol       Date:  2018-09-28

Review 3.  Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications.

Authors:  Ben Brannick; Anne Wynn; Samuel Dagogo-Jack
Journal:  Exp Biol Med (Maywood)       Date:  2016-06

4.  Metabolomic prediction of diabetes and cardiovascular risk.

Authors:  Samuel Dagogo-Jack
Journal:  Med Princ Pract       Date:  2012-06-15       Impact factor: 1.927

Review 5.  Evaluation of skin lesions in diabetic patients: a systematic review and meta-analysis.

Authors:  Nader Salari; Amin Hosseinian-Far; Melika Hosseinian-Far; Hossein Kavoussi; Rostam Jalali; Aliakbar Vaisi-Raygani; Shabnam Rasoulpoor; Shna Rasoulpoor; Masoud Mohammadi; Shervin Shabani
Journal:  J Diabetes Metab Disord       Date:  2020-09-09

6.  Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease.

Authors:  Takeshi Nishi; Yuichi Saito; Hideki Kitahara; Tomoko Nishi; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Intern Med       Date:  2020-11-02       Impact factor: 1.271

7.  Prediabetes and type 2 diabetes mellitus: Evidence for effect of yoga.

Authors:  Viveka P Jyotsna
Journal:  Indian J Endocrinol Metab       Date:  2014-11

8.  Risk Factors for and Barriers to Control Type-2 Diabetes among Saudi Population.

Authors:  Yahya Mari Alneami; Christopher L Coleman
Journal:  Glob J Health Sci       Date:  2016-09-01

Review 9.  Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.

Authors:  Arun Chaudhury; Chitharanjan Duvoor; Vijaya Sena Reddy Dendi; Shashank Kraleti; Aditya Chada; Rahul Ravilla; Asween Marco; Nawal Singh Shekhawat; Maria Theresa Montales; Kevin Kuriakose; Appalanaidu Sasapu; Alexandria Beebe; Naveen Patil; Chaitanya K Musham; Govinda Prasad Lohani; Wasique Mirza
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-24       Impact factor: 5.555

Review 10.  Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective.

Authors:  Iftikhar Alam; Tze Pin Ng; Anis Larbi
Journal:  Mediators Inflamm       Date:  2012-10-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.